Literature DB >> 18677636

Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients.

E F Goodall1, M S Haque, K E Morrison.   

Abstract

Iron misregulation promotes oxidative stress, a proposed pathological mechanism in neurodegenerative disease. The aim of this study was to evaluate serum iron metabolism indicators in 60 amyotrophic lateral sclerosis (ALS) patients and 44 age matched controls. Serum ferritin levels were significantly increased in ALS patients compared to controls (p < 0.001), while no differences in the levels of serum iron, transferrin, iron saturation or total iron binding capacity were found. Likewise no differences in C reactive protein (CRP) or caeruloplasmin were detected, suggesting that the elevated ferritin levels in ALS did not merely indicate an acute phase response. The increased ferritin level may reflect a general increase in stored iron or be a consequence of ongoing muscle degeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18677636     DOI: 10.1007/s00415-008-0945-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  Cerebrospinal fluid ferritin in human disease.

Authors:  E Zappone; V Bellotti; M Cazzola; M Ceroni; F Meloni; P Pedrazzoli; V Perfetti
Journal:  Haematologica       Date:  1986 Mar-Apr       Impact factor: 9.941

2.  Superoxide dismutase 1 modulates expression of transferrin receptor.

Authors:  Ruth Danzeisen; Tilmann Achsel; Ulrich Bederke; Mauro Cozzolino; Claudia Crosio; Alberto Ferri; Malte Frenzel; Edith Butler Gralla; Lea Huber; Albert Ludolph; Monica Nencini; Giuseppe Rotilio; Joan Selverstone Valentine; Maria Teresa Carrì
Journal:  J Biol Inorg Chem       Date:  2006-04-26       Impact factor: 3.358

3.  Transferrin localizes in Bunina bodies in amyotrophic lateral sclerosis.

Authors:  Yuji Mizuno; Masakuni Amari; Masamitsu Takatama; Hitoshi Aizawa; Ban Mihara; Koichi Okamoto
Journal:  Acta Neuropathol       Date:  2006-08-05       Impact factor: 17.088

4.  Serum ferritin as a measure of iron stores in normal subjects.

Authors:  J D Cook; D A Lipschitz; L E Miles; C A Finch
Journal:  Am J Clin Nutr       Date:  1974-07       Impact factor: 7.045

5.  Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?

Authors:  C Moreau; D Devos; V Brunaud-Danel; L Defebvre; T Perez; A Destée; A B Tonnel; P Lassalle; N Just
Journal:  Neurology       Date:  2005-12-27       Impact factor: 9.910

6.  Neutron activation analysis of trace elements in motor neuron disease spinal cord.

Authors:  W R Markesbery; W D Ehmann; J M Candy; P G Ince; P J Shaw; L Tandon; M A Deibel
Journal:  Neurodegeneration       Date:  1995-12

7.  Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease.

Authors:  P G Ince; P J Shaw; J M Candy; D Mantle; L Tandon; W D Ehmann; W R Markesbery
Journal:  Neurosci Lett       Date:  1994-11-21       Impact factor: 3.046

8.  Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study.

Authors:  E J Kasarskis; L Tandon; M A Lovell; W D Ehmann
Journal:  J Neurol Sci       Date:  1995-06       Impact factor: 3.181

9.  Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production.

Authors:  Florian L Muller; Wook Song; Youngmok C Jang; Yuhong Liu; Marian Sabia; Arlan Richardson; Holly Van Remmen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-06-20       Impact factor: 3.619

10.  Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences.

Authors:  Xin-Sheng Wang; Sang Lee; Zachary Simmons; Philip Boyer; Kevin Scott; Wenlei Liu; James Connor
Journal:  J Neurol Sci       Date:  2004-12-15       Impact factor: 3.181

View more
  21 in total

1.  Amyotrophic lateral sclerosis, enteral nutrition and the risk of iron overload.

Authors:  Alessio Molfino; Irma Kushta; Valentina Tommasi; Filippo Rossi Fanelli; Maurizio Muscaritoli
Journal:  J Neurol       Date:  2009-02-25       Impact factor: 4.849

2.  Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis.

Authors:  Andrew D Schweitzer; Tian Liu; Ajay Gupta; Karen Zheng; Stephen Seedial; Alexander Shtilbans; Mona Shahbazi; Dale Lange; Yi Wang; A John Tsiouris
Journal:  AJR Am J Roentgenol       Date:  2015-05       Impact factor: 3.959

3.  Serum ferritin is a candidate biomarker of disease aggravation in amyotrophic lateral sclerosis.

Authors:  Jixu Yu; Nian Wang; Faying Qi; Xianjun Wang; Qiyi Zhu; Yucheng Lu; Huiling Zhang; Fengyuan Che; Wei Li
Journal:  Biomed Rep       Date:  2018-08-02

4.  Autophagy-Independent Lysosomal Targeting Regulated by ULK1/2-FIP200 and ATG9.

Authors:  Jonathan M Goodwin; William E Dowdle; Rowena DeJesus; Zuncai Wang; Philip Bergman; Marek Kobylarz; Alicia Lindeman; Ramnik J Xavier; Gregory McAllister; Beat Nyfeler; Gregory Hoffman; Leon O Murphy
Journal:  Cell Rep       Date:  2017-09-05       Impact factor: 9.423

5.  Interactions of ferritin with scavenger receptor class A members.

Authors:  Bowen Yu; Chen Cheng; Yichun Wu; Luqiang Guo; Dandan Kong; Ze Zhang; Yuanyuan Wang; Enlin Zheng; Yingbin Liu; Yongning He
Journal:  J Biol Chem       Date:  2020-09-09       Impact factor: 5.157

6.  Essential trace elements in amyotrophic lateral sclerosis (ALS): Results in a population of a risk area of Italy.

Authors:  Giovanni Forte; Beatrice Bocca; Riccardo Oggiano; Simonetta Clemente; Yolande Asara; Maria Alessandra Sotgiu; Cristiano Farace; Andrea Montella; Alessandro Giuseppe Fois; Michele Malaguarnera; Pietro Pirina; Roberto Madeddu
Journal:  Neurol Sci       Date:  2017-06-10       Impact factor: 3.307

7.  Iron and restless legs syndrome: treatment, genetics and pathophysiology.

Authors:  James R Connor; Stephanie M Patton; Konrad Oexle; Richard P Allen
Journal:  Sleep Med       Date:  2016-11-10       Impact factor: 3.492

Review 8.  Metal ion physiopathology in neurodegenerative disorders.

Authors:  Silvia Bolognin; Luigi Messori; Paolo Zatta
Journal:  Neuromolecular Med       Date:  2009-11-28       Impact factor: 3.843

9.  Statins accelerate disease progression and shorten survival in SOD1(G93A) mice.

Authors:  Xiaowei W Su; Wint Nandar; Elizabeth B Neely; Zachary Simmons; James R Connor
Journal:  Muscle Nerve       Date:  2016-05-19       Impact factor: 3.217

Review 10.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.